One of the largest pharmacy operators in the country, TerryWhite Chemmart-owner Ebos, says the $8.8 billion merger of its two rivals, Sigma Healthcare and Chemist Warehouse, should be stopped because it will put smaller companies out of business and reduce consumers’ choices.
John Cullity, the chief executive of the ASX-listed group, said Chemist Warehouse was already a dominant player in the industry and the merger, which is being assessed by the Australian Competition and Consumer Commission, would “allow it to get stronger”.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
